Aria 2016 executive summary: Integrated care pathways for predictive medicine across the life cycle; [ARIA 2016 yönetici özeti: Yaşam döngüsü boyunca hastalıkları öngörmeye yönelik tıp uygulamaları için bütünleştirilmiş yaklaşım yolakları]

dc.contributor.authorYorgancioğlu A.A.
dc.contributor.authorKalayci Ö.
dc.contributor.authorCingi C.
dc.contributor.authorGemicioğlu B.
dc.contributor.authorKalyoncu A.F.
dc.contributor.authorAgache I.
dc.contributor.authorBachert C.
dc.contributor.authorBedbrook A.
dc.contributor.authorCanonica G.W.
dc.contributor.authorCasale T.
dc.contributor.authorCruz A.
dc.contributor.authorFokkens W.E.
dc.contributor.authorHellings P.
dc.contributor.authorSamolinski B.
dc.contributor.authorBousquet J.
dc.date.accessioned2024-07-22T08:11:06Z
dc.date.available2024-07-22T08:11:06Z
dc.date.issued2017
dc.description.abstractThe Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA-disseminated and implemented in over 70 countries globally- is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK (MACVIA (Contre les MAladies Chroniques pour un VIeillissement Actif)-ARIA Sentinel NetworK) uses mobile technology to develop care pathways in order to enable the management of rhinitis and asthma by a multidisciplinary group or by patients themselves. An App (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease. © 2017, Ankara University. All rights reserved.
dc.identifier.DOI-ID10.5578/tt.52766
dc.identifier.issn04941373
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15508
dc.language.isoTurkish
dc.publisherAnkara University
dc.rightsAll Open Access; Bronze Open Access
dc.subjectAging
dc.subjectAsthma
dc.subjectDecision Support Techniques
dc.subjectDelivery of Health Care, Integrated
dc.subjectHumans
dc.subjectRhinitis, Allergic
dc.subjectRhinitis, Allergic, Seasonal
dc.subjectTurkey
dc.subjectVisual Analog Scale
dc.subjectWorld Health Organization
dc.subjectallergic rhinitis
dc.subjectasthma
dc.subjectclinical decision support system
dc.subjectevidence based medicine
dc.subjecthealth care personnel
dc.subjecthuman
dc.subjectlife cycle
dc.subjectmedical society
dc.subjectmobile application
dc.subjectmorbidity
dc.subjectphysician
dc.subjectproductivity
dc.subjectReview
dc.subjectsocial status
dc.subjectvisual analog scale
dc.subjectworld health organization
dc.subjectaging
dc.subjectallergic rhinitis
dc.subjectasthma
dc.subjectclassification
dc.subjectcomplication
dc.subjectdecision support system
dc.subjectintegrated health care system
dc.subjectphysiology
dc.subjectpollen allergy
dc.subjectpsychology
dc.subjectTurkey
dc.titleAria 2016 executive summary: Integrated care pathways for predictive medicine across the life cycle; [ARIA 2016 yönetici özeti: Yaşam döngüsü boyunca hastalıkları öngörmeye yönelik tıp uygulamaları için bütünleştirilmiş yaklaşım yolakları]
dc.typeReview

Files